β-Catenin Signaling in Hepatocellular Carcinoma: Mechanisms of Therapeutic Resistance and Emerging Therapeutic Strategies
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with poor patient outcomes largely attributable to late diagnosis and the frequent development of therapeutic resistance. Although advances in chemotherapy, targeted therapies, immunotherapy, and combination regimens have improved...